SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-003999
Filing Date
2024-02-15
Accepted
2024-02-15 20:37:12
Documents
1
Period of Report
2024-02-13

Document Format Files

Seq Description Document Type Size
1 form4-02162024_010205.html 4  
1 form4-02162024_010205.xml 4 4122
  Complete submission text file 0001415889-24-003999.txt   5548
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Issuer) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KEROS THERAPEUTICS, INC. 99 HAYDEN AVE., BUILDING E, SUITE 120 LEXINGTON MA 02421
Business Address
Cooper Simon Peter (Reporting) CIK: 0001877225 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 24645542